Simnotrelvir to reduces the symptoms of mild to moderate COVID-19

1. In this randomized controlled trial, patients experiencing symptomatic coronavirus disease 2019 (COVID-19) saw significant improvement in symptom resolution times compared to the placebo group. 2. Further investigation is needed to specifically delineate the impact of simnotrelvir on older COVID-19 patients.  Evidence Rating Level: 1 (Excellent) Study Rundown: COVID-19 has been a major public health […]

The post Simnotrelvir to reduces the symptoms of mild to moderate COVID-19 first appeared on 2 Minute Medicine.